Israel Active

I was suspicious of the BBC’s report on the “innovative” US immunotherapy that cured 27 of 29 “no-hope” leukemia patients. Sure enough, the genetic modification of T-cells was developed by Weizmann Institute Professor Zelig Eshhar, and the US researchers accredited him.

Tel Aviv University Professor Itzhak Fried has completed his study of how memory neurons behave in real time when they are “remembering.” He will present his findings at an upcoming Jerusalem symposium. These have important implications for understanding dementia such as Alzheimer’s.

A US surgeon, confined to a wheelchair following a spinal cord injury, has successfully won his case to be reimbursed by his health plan for a ReWalk exoskeleton. The ruling will help make ReWalk available to all eligible patients.

Russia’s most dominant email service Mail.Ru is integrating the database of Archimedicx. Health Mail.Ru is one of the most popular health portals in Russia. Israeli Moni Milchman developed ArchimedicX, the world’s first search engine for information about hospitals.

Israeli Science, Technology and Space Minister Ofir Akunis signed a biotechnology agreement with the California Institute for Regenerative Medicine (CIRM) Its focus is stem cell research and breakthroughs in treating diseases such as cancer, diabetes, Alzheimer’s and HIV-AIDS.  

Israel’s Vigor Medical Technologies won the Innovex Disrupt contest at Tel Aviv’s Innovex2016 conference. Vigor’s sealant system treats thoracic trauma, a chest injury that can cause the lungs to collapse. If treated within one hour, the patient has an 80% survival chance.

Israel’s Dr. Shira Knafo heads Spain’s Molecular Cognition Laboratory at BioCruces Health Research Institute. She has discovered a small protein, which inhibits the processes normally associated with impairment, including depression and Alzheimer’s disease.

Kytera is another Israeli startup that has developed innovative sensor technology to keep a close eye on at-risk seniors. It also collects anonymous data that can be used to provide vital research on specific illnesses or medications.

I reported on Israel’s V-Wave when it implanted its first heart shunt to treat congestive heart failure patients. It has since successfully treated over 30 patients. V-Wave has just raised $28 million to expand clinical evaluation, development and production.

Professor Yonina Eldar at Israel’s Technion is developing an innovative portable ultrasound system that transmits scans to the treating physician immediately. Scans can be performed in disaster areas, at road accidents, and in developing countries where the medical infrastructure is limited.